...Care Becomes a Reality With Tempus, CancerLinQ and Precision HealthAI Deal Eric Lefkofsky's company is about to make personalized cancer treatment a reality. As the CEO of Tempus, Lefkofsky has spearheaded an initiative that uses big data to personalize different types of cancer treatment. Tempus is a technology company that recently started a deal with Precision HealthAI and CancerLinQ to structure data. Currently, the CancerLinQ database includes one million records from patients. Precision HealthAI and Tempus will help CancerLinQ analyze their database more efficiently and more quickly than they were previously able to. In an interview, Tempus CEO Eric Lefkofsky discussed the coming deal. CancerLinQ originally formed...
Words: 526 - Pages: 3